Saliva and inhibition of HIV-1 infection: molecular mechanisms

被引:38
作者
Shugars, DC
Sweet, SP
Malamud, D
Kazmi, S
Page-Shafer, K
Challacombe, SJ
机构
[1] Univ N Carolina, Sch Dent, Dept Dent, Chapel Hill, NC USA
[2] Univ N Carolina, Sch Dent, Dept Med, Chapel Hill, NC USA
[3] Guys Hosp, Dept Oral Med Pathol Microbiol & Immunol, London SE1 9RT, England
[4] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA
[5] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent, San Francisco, CA USA
关键词
HIV; antiviral; saliva; transmission; mucosal immunity; antibody testing;
D O I
10.1034/j.1601-0825.8.s2.7.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Oral fluids are rarely a vehicle for HIV-1 infection in vivo, unlike other mucosal secretions. This unique property raises questions regarding (1) the molecular mechanisms responsible for the lack of salivary transmission, (2) the extent to which oral immunological responses mirror responses at other mucosal sites, (3) the use of promising salivary markers of HIV-1 disease progression, (4) the relationship between oral and blood viral loads, (5) cofactors that influence oro-genital transmission, and (6) the feasibility of oral-based antibody testing for HIV-1 diagnosis in the home. This paper discusses these questions and provides background summaries, findings from new studies, consensus opinions, practical relevance to developing countries, and suggestions for future research agenda on each of the key topics.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 53 条
[41]   Clinical and epidemiologic features of primary HIV infection [J].
Schacker, T ;
Collier, AC ;
Hughes, J ;
Shea, T ;
Corey, L .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (04) :257-+
[42]  
Shugars D C, 1997, Oral Dis, V3 Suppl 1, pS70
[43]   Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva [J].
Shugars, DC ;
Slade, GD ;
Patton, LL ;
Fiscus, SA .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 2000, 89 (04) :432-440
[44]   The role of the oral environment in HIV-1 transmission [J].
Shugars, DC ;
Wahl, SM .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1998, 129 (07) :851-858
[45]  
SHUGARS DC, 2002, IN PRESS ORAL DIS S1, V8
[46]  
SPICKETT GP, 1988, CLIN EXP IMMUNOL, V71, P1
[47]   ANTIMICROBIAL ACTIONS OF CALCIUM-BINDING LEUKOCYTE L1 PROTEIN, CALPROTECTIN [J].
STEINBAKK, M ;
NAESSANDRESEN, CF ;
LINGAAS, E ;
DALE, I ;
BRANDTZAEG, P ;
FAGERHOL, MK .
LANCET, 1990, 336 (8718) :763-765
[48]  
Sweet SP, 1995, IMMUNOLOGY, V86, P556
[49]  
SWEET SP, 2000, IN PRESS ORAL MICROB
[50]   Sexual transmission of HIV: infectiousness and prevention [J].
Vernazza, PL ;
Eron, JJ ;
Fiscus, SA ;
Cohen, MS .
AIDS, 1999, 13 (02) :155-166